Skip to content

Clinical trials

Myeloproliferative Disorders trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Unknown status Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20131

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center1
Herbert Irving Comprehensive Cancer Center1
Medical College of Wisconsin1
Milton S. Hershey Medical Center1
The Cleveland Clinic1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders6
Blast Crisis5
Leukemia, Lymphocytic, Chronic, B-Cell5
Leukemia, Myeloid, Accelerated Phase5
Leukemia, Myeloid, Chronic-Phase5
Multiple Myeloma5
Myelodysplastic Syndromes5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Burkitt Lymphoma4
Dendritic Cell Sarcoma, Interdigitating4

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.